CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Income Statement [Abstract]
Revenues	$ 716
Research and development expenses	(12,706)	(8,311)	(6,123)
Less participation by the Office of the Chief Scientist and other parties	3,527	1,682	1,822
Research and development expenses, net	(9,179)	(6,629)	(4,301)
General and administrative expenses	(6,568)	(4,485)	(3,138)
Operating loss	(15,031)	(11,114)	(7,439)
Financial income (expenses), net	237	266	(14)
Net loss for the period	$ (14,794)	$ (10,848)	$ (7,453)
Loss per share:
Basic and diluted net loss per share	$ (0.34)	$ (0.35)	$ (0.44)
Weighted average number of shares used in computing basic and diluted net loss per share	44,031,866	31,198,825	17,004,998